VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,733,264 | +389.2% | 632,700 | +646.2% | 0.00% | – |
| Q2 2023 | $558,766 | -11.8% | 84,790 | -9.1% | 0.00% | – |
| Q1 2023 | $633,588 | +19.4% | 93,312 | +30.0% | 0.00% | – |
| Q4 2022 | $530,476 | -54.9% | 71,783 | -39.7% | 0.00% | – |
| Q3 2022 | $1,176,000 | +154.0% | 118,971 | +179.7% | 0.00% | – |
| Q2 2022 | $463,000 | -71.4% | 42,541 | -70.3% | 0.00% | – |
| Q1 2022 | $1,621,000 | -90.0% | 143,257 | -86.2% | 0.00% | – |
| Q4 2021 | $16,240,000 | +624.7% | 1,035,054 | +691.4% | 0.00% | – |
| Q3 2021 | $2,241,000 | -33.6% | 130,788 | -16.6% | 0.00% | – |
| Q2 2021 | $3,374,000 | -8.5% | 156,879 | -36.1% | 0.00% | – |
| Q1 2021 | $3,689,000 | +62.4% | 245,604 | +42.1% | 0.00% | – |
| Q4 2020 | $2,272,000 | +14.1% | 172,866 | -16.2% | 0.00% | – |
| Q3 2020 | $1,992,000 | -63.5% | 206,236 | -56.8% | 0.00% | -100.0% |
| Q2 2020 | $5,460,000 | +130.3% | 477,279 | +108.6% | 0.00% | – |
| Q1 2020 | $2,371,000 | -23.6% | 228,786 | +20.9% | 0.00% | -100.0% |
| Q4 2019 | $3,104,000 | +25.4% | 189,166 | +1.5% | 0.00% | – |
| Q3 2019 | $2,476,000 | -65.7% | 186,432 | -63.6% | 0.00% | -100.0% |
| Q2 2019 | $7,222,000 | +68.1% | 512,439 | +119.5% | 0.00% | 0.0% |
| Q1 2019 | $4,296,000 | +698.5% | 233,504 | +1033.5% | 0.00% | – |
| Q4 2018 | $538,000 | +8.9% | 20,600 | -4.2% | 0.00% | – |
| Q3 2018 | $494,000 | -21.8% | 21,500 | -35.2% | 0.00% | – |
| Q2 2018 | $632,000 | -71.1% | 33,200 | -74.5% | 0.00% | -100.0% |
| Q1 2018 | $2,190,000 | +257.8% | 129,955 | +222.9% | 0.00% | – |
| Q4 2017 | $612,000 | -60.0% | 40,248 | -52.9% | 0.00% | – |
| Q3 2017 | $1,529,000 | +90.9% | 85,400 | +73.6% | 0.00% | – |
| Q2 2017 | $801,000 | +8.0% | 49,200 | -7.2% | 0.00% | – |
| Q1 2017 | $742,000 | -88.9% | 53,000 | -87.3% | 0.00% | -100.0% |
| Q4 2016 | $6,671,000 | -34.7% | 418,212 | -31.8% | 0.00% | -25.0% |
| Q3 2016 | $10,210,000 | +292.5% | 613,599 | +164.0% | 0.00% | +300.0% |
| Q2 2016 | $2,601,000 | +88.9% | 232,413 | +41.2% | 0.00% | – |
| Q1 2016 | $1,377,000 | -60.5% | 164,628 | -56.1% | 0.00% | -100.0% |
| Q4 2015 | $3,489,000 | -34.4% | 374,755 | -20.5% | 0.00% | -50.0% |
| Q3 2015 | $5,317,000 | -10.6% | 471,365 | +0.6% | 0.00% | 0.0% |
| Q2 2015 | $5,947,000 | -45.4% | 468,645 | -60.0% | 0.00% | -60.0% |
| Q1 2015 | $10,899,000 | +64.7% | 1,171,892 | +153.6% | 0.01% | +150.0% |
| Q4 2014 | $6,618,000 | +40.7% | 462,151 | +2.0% | 0.00% | +100.0% |
| Q3 2014 | $4,704,000 | -65.0% | 453,097 | -45.5% | 0.00% | -83.3% |
| Q2 2014 | $13,452,000 | -38.6% | 831,429 | -38.4% | 0.01% | -40.0% |
| Q1 2014 | $21,920,000 | +58.4% | 1,348,948 | +21.0% | 0.01% | +66.7% |
| Q4 2013 | $13,837,000 | -18.7% | 1,115,056 | -28.1% | 0.01% | -33.3% |
| Q3 2013 | $17,019,000 | +135.3% | 1,551,400 | +73.3% | 0.01% | +80.0% |
| Q2 2013 | $7,234,000 | – | 895,335 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |